When assessing chemical safety, most regulatory frameworks still evaluate substances individually. However, in our daily lives, we are environmentally exposed to a wide variety of substances – via the air we breath, the water we drink, the food we eat and the many consumer products we use every day. The NEMESIS project takes a crucial step forward […]

In October 2024, the Wincent Lab at Karolinska Institutet started testing the effects of NEMESIS focus-compounds on adverse outcomes using zebrafish, a non-mammalian model, as part of the in vivo work done in the NEMESIS project. Malin Lundvall, a Master’s student, and Oscar Diaz, Postdoc, performed the initial testing and evaluated the effects of 8 […]

NEMESIS has run for just over one year and it was time to see where the project is at. The consortium members met at a General Assembly meeting in Barcelona on 29-30 January 2025 to discuss the progress of the project and the next steps. The meeting was arranged at CSIC Spanish National Research Council […]

Subscribe now to receive in your inbox the ENKORE Cluster newsletter on the latest news and advances on the health impacts of endocrine-disrupting chemicals from European research institutions and five Horizon Europe funded projects: NEMESIS as well as EDC-MASLD, ENDOMIX, HYPIEND and MERLON. During the ENKORE cluster lifespan, just a total of three newsletters will be sent with cluster […]